Blog

DEEP RESEARCH · Wooyang HC

Wooyang HC: 2026 Order Recognition Matters More Than Q4 Slowdown

Chemical-plant cash cow, LNG/SMR/CCUS optionality, and post-SPAC merger turnaround

Date: 2026-01-30 · Q4 results/2026 outlook · Original Naver Blog post

Investment decisions are your responsibility. This research is not a buy or sell recommendation.

0. Bottom line first

Wooyang HC's Q4 2025 preliminary results look weak on the surface, but I separate temporary SPAC-merger effects and delayed North American project FIDs from the underlying business. The core is 2026 revenue recognition from North American LNG projects and an order pipeline expanding into nuclear, SMR, and CCUS.

  • Chemical plants accounted for 94.9% of 2024 revenue in the source.
  • Energy plants were 0.88% and eco plants 4.25%; small today, but meaningful options.
  • Operating cash flow was cited at about KRW 24.1 billion at end-2024 and about KRW 30.5 billion cumulative through Q3 2025.
  • The source says short-term borrowings of about KRW 23.5 billion were fully repaid in 2025, improving financial stability.

1. Business Portfolio

SegmentMain products2024 revenue shareMain customers
Chemical plantReactors, heat exchangers, towers, pressure vessels94.9%Bechtel, Technip, Samsung ENGR
Energy plantCondensers, feedwater heaters, deaerators, BOP0.88%KEPCO, KHNP
Eco plantWater-treatment equipment, ZLD systems, CCUS4.25%Hyundai E&C, Lotte Chemical
Wooyang HC growth pathFrom chemical cash cow to carbon-free power equipment
Chemical94.9% of revenue
LNGNorth American projects
SMRQualified KHNP supplier
CCUSEco-plant option
The key is whether existing backlog turns into 2026 revenue.

2. Cash Flow and Financial Strength

Official fact: The source cites operating cash flow of about KRW 24.1 billion at end-2024 and about KRW 30.5 billion cumulative through Q3 2025. It also says about KRW 23.5 billion of short-term borrowings was fully repaid in 2025.

Interpretation: If advances and receivables collection remained healthy despite lower revenue, cash generation quality was not damaged. Financing volatility related to the SPAC merger should be separated from operating capability.

3. 2026 Turnaround Numbers

Metric2025 estimate/base2026 outlookChange
RevenueAbout KRW 100.8bnAbout KRW 211.5bn+109.8%
Operating profitAbout KRW 0.96bnAbout KRW 29.2bn+2,941.6%
Net incomeLoss, about -KRW 4.2bnAbout KRW 22.9bnTurn to profit
  • The KRW 42.6 billion North American LNG project contract with Bechtel signed in October 2025 can begin recognizing progress revenue in 2026.
  • Delayed U.S. large-project FIDs may concentrate in H1 2026, creating further order expectations.
  • Removal of one-off merger expenses and utilization recovery above 70% support the return-to-double-digit operating-margin thesis.

4. Policy Tailwinds: 11th Power Plan, SMR, CCUS

CFE

Carbon-free power

The source says the 11th electricity plan targets a 70.7% carbon-free power share by 2038.

SMR

Small modular reactors

Plans for three large reactors and one SMR commercialization are options for Wooyang's nuclear BOP experience.

CCUS

Eco plant

National-project work on low-carbon fuel using CO2 from the cement industry is presented as a new growth driver.

5. Risks

  • FI stakes and lockup expiration after relisting can create overhang.
  • In September 2025, all existing private convertible bonds were converted, issuing 242,300 common shares.
  • The business has FX exposure because of high foreign-currency settlement; the source says currency-option contracts with KB Kookmin Bank and others are used for hedging.

6. Final View

For Wooyang HC, I focus less on the past delisting history and more on current backlog, near-debt-free financial improvement, and LNG/SMR/CCUS expansion. I think 2026 can be the first year in which the company is revalued as a global plant-equipment supplier.

Sources

Naver original